Hisamitsu Pharmaceutical Co (TSE:4530) Other Long Term Assets : 円78,139 Mil (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Other Long Term Assets?

Hisamitsu Pharmaceutical Co's other long-term assets for the quarter that ended in Nov. 2023 was 円78,139 Mil.

Hisamitsu Pharmaceutical Co's quarterly other long-term assets increased from May. 2023 (円72,737 Mil) to Aug. 2023 (円77,499 Mil) and increased from Aug. 2023 (円77,499 Mil) to Nov. 2023 (円78,139 Mil).

Hisamitsu Pharmaceutical Co's annual other long-term assets increased from Feb. 2022 (円62,289 Mil) to Feb. 2023 (円70,589 Mil) and increased from Feb. 2023 (円70,589 Mil) to Feb. 2024 (円78,465 Mil).

Hisamitsu Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Other Long Term Assets Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Other Long Term Assets

Get a 7-Day Free Trial

58,085.00

63,269.00

62,289.00

70,589.00

78,465.00

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Other Long Term Assets	Get a 7-Day Free Trial															70,589.00	72,737.00	77,499.00	78,139.00	78,465.00

Hisamitsu Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines